Last update Jan. 3, 2022
Very Low Risk
Immunoglobulins (Ig) are proteins produced by B lymphocytes as a humoral response to antigens foreign to the body itself. The immunoglobulins used in clinical practice are preparations from human serum or plasma that contain antibodies, mainly IgG.
Its very high molecular weight make it highly unlikely that significant quantities will pass into breast milk. Administration of standard immunoglobulin does not significantly alter the levels of immunoglobulins (IgG or IgM) in colostrum or breast milk. (Palmeira 2009)
No problems have been observed in infants whose mothers are treated with immunoglobulin for various diseases (Gan 2012, Haas 2007 and 2000, Achiron 2004), except for one case of a rash that resolved spontaneously. (Bostan 2020)
Several medical societies and expert authors consider the use of this medication safe during breastfeeding. (Hale, LactMed, Flint 2016, Götestam 2016, Briggs 2016, Schaefer 2015, Butler 2014, Houtchens 2013, Østensen 2006)
List of WHO essential medicines: compatible with breastfeeding. (WHO / UNICEF 2002)
We do not have alternatives for Human Immune globulin since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Asociación Española de Bancos de Leche Humana of Spain
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM